GELEEN, Netherlands--(BUSINESS WIRE)-- DSM Biomedical, a global company serving the medtech and biotech industries and part of Royal DSM N.V., announced today that it has extended its lubricious ComfortCoat™ technology platform with the design of a hemocompatible antimicrobial coating to thwart intravascular catheter-related bloodstream infections.
